돼지풀 화분 알레르기 치료 시장 : 약물 계열별, 유통 채널별, 지역별

Ragweed Pollen Allergy Treatment Market is estimated to be valued at USD 1,095.0 Mn in 2026 and is expected to reach USD 1,520.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.

Ragweed is an allergen for people allergic to ragweed. Ragweed pollen is made of tiny particles that float through the air and cause allergy symptoms in people who are allergic to ragweed. Of all ragweed allergy symptoms, cough, runny nose, and an itchy throat are the most common. Ragweed pollen is a powdery substance that consists of tiny particles, or grains. The grains of pollen help fertilize other ragweed plants. One ragweed plant can produce up to 1 billion pollen grains that can float through the air, and either produce seeds or end up in the nose, eyes or mouth, causing great discomfort if a person is allergic to it. Pollen can also collect on clothes, hair, and the skin. Like all pollen allergies, allergies to ragweed can lead to seasonal allergic rhinitis (hay fever), inflammation of the nasal passages. For people with a ragweed allergy, exposure to the plant by touch or through airborne particles can lead to them developing a ragweed rash. Other common ragweed allergy symptoms are: nasal congestion, runny nose with thin, water discharge, postnasal drip, sneezing, coughing, watery, itchy or irritated eyes, eye swelling- the "allergic shiner", weakness or fatigue, hives on the skin. A person who has been exposed to ragweed pollen may notice itchy red streaks appearing on his skin 24 to 48 hours after exposure. The rash can be painful and may form into blisters. Ragweed rash can last anywhere from two to three weeks and will usually improve on its own. Ragweed pollen can cause asthma symptoms to flare up. When a person with asthma and ragweed allergy inhales ragweed pollen, it can cause the lungs and airways to become inflamed and swollen. People with allergic asthma will require treatment for its asthma symptoms, but they may also require treatment for its allergies.

Market Dynamics

Increasing launches of new products, and mergers and acquisitions by key market players is expected to drive the global ragweed pollen allergy treatment market growth. For instance, on April 19, 2021, ALK, a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy, announced that the U.S. Food and Drug Administration (FDA) approved RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the treatment of short ragweed pollen-induced allergic rhinitis in persons ages five through 65. RAGWITEK is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global ragweed pollen allergy treatment market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, and Astellas Pharma Inc., Thermo Fisher Scientific Inc, Siemens Healthcare Private Limited, Omega Diagnostics Group PLC, Stallergenes Greer, bioMerieux SA, Lincoln Diagnostics, Inc, HOB Biotech Group Corp Ltd, HYCOR Biomedical, Inc, Alcon, Hitachi Chemical Diagnostics, Inc, Quest Diagnostics Incorporated, Circassia, Immunomic Therapeutics, Inc, Novartis AG, Japan Tobacco Inc, GlaxoSmithKline plc, REGiMMUNE Co, Ltd, Sanofi, and Merck KGaA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global ragweed pollen allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ragweed pollen allergy treatment market

Detailed Segmentation:

• Global Ragweed Pollen Allergy Treatment Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)
• Antihistamines
• Decongestants
• Nasal Corticosteroids
• Others
• Global Ragweed Pollen Allergy Treatment Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
• Hospital Pharmacy
• Retail Pharmacy
• Online Channel
• Global Ragweed Pollen Allergy Treatment Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
• Asia Pacific
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• ALK-Abello A/S
• ASIT Biotech SA
• Anergis SA
• Biomay AG
• Astellas Pharma Inc.
• Thermo Fisher Scientific Inc
• Siemens Healthcare Private Limited
• Omega Diagnostics Group PLC
• Stallergenes Greer
• bioMerieux SA
• Lincoln Diagnostics, Inc
• HOB Biotech Group Corp Ltd
• HYCOR Biomedical, Inc
• Alcon
• Hitachi Chemical Diagnostics, Inc
• Quest Diagnostics Incorporated
• Circassia
• Immunomic Therapeutics, Inc
• Novartis AG
• Japan Tobacco Inc
• GlaxoSmithKline plc
• REGiMMUNE Co, Ltd
• Sanofi
• Merck KGaA.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Ragweed Pollen Allergy Treatment Market, By Drug Class, 2021-2033, (US$ Million)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Antihistamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Decongestants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Nasal Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Ragweed Pollen Allergy Treatment Market, By Distribution Channel, 2021-2033, (US$ Million)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Online Channel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Ragweed Pollen Allergy Treatment Market, By Region, 2021-2033, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• ALK-Abello A/S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ASIT Biotech SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Anergis SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biomay AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Astellas Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Thermo Fisher Scientific Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Siemens Healthcare Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Omega Diagnostics Group PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Stallergenes Greer
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lincoln Diagnostics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• HOB Biotech Group Corp Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• HYCOR Biomedical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Alcon
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Hitachi Chemical Diagnostics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Quest Diagnostics Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Circassia
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Immunomic Therapeutics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Japan Tobacco Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• REGiMMUNE Co, Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us